MedTrace Logo

Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19

NCT04397939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4695

Last updated 2024-03-08

Study results available
· View outcomes & findings →

Summary

The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical characteristics, biomarkers, cardiac tests data and treatment approaches to uncover the potential mechanisms responsible for COVID-19 induced myocardial injury.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Annapoorna Kini, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-08
Primary Completion
2022-03-01
Completion
2022-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397939 on ClinicalTrials.gov